These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31754820)
1. Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT. Zhang J; Chen Y; Zhang Y; Zhang E; Yu HJ; Yuan H; Zhang Y; Su MY; Lang N Eur Spine J; 2020 May; 29(5):1061-1070. PubMed ID: 31754820 [TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI versus Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Dynamic Contrast-Enhanced MRI and Zhang Y; Zhao H; Liu Y; Zeng M; Zhang J; Hao D Acad Radiol; 2022 Dec; 29(12):1842-1851. PubMed ID: 35396157 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207 [TBL] [Abstract][Full Text] [Related]
5. Correlation Between Tumor Metabolism and Semiquantitative Perfusion Magnetic Resonance Imaging Metrics in Non-Small Cell Lung Cancer. Lee SH; Rimner A; Gelb E; Deasy JO; Hunt MA; Humm JL; Tyagi N Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):718-726. PubMed ID: 29680254 [TBL] [Abstract][Full Text] [Related]
6. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors. An YS; Kang DK; Jung YS; Han S; Kim TH Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700 [TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
8. Correlation Between F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Parameters and Dynamic Contrast-Enhanced MRI-Derived Perfusion Data in Patients with Invasive Ductal Breast Carcinoma. Kim TH; Yoon JK; Kang DK; Lee SJ; Jung YS; Yim H; An YS Ann Surg Oncol; 2015 Nov; 22(12):3866-72. PubMed ID: 25805237 [TBL] [Abstract][Full Text] [Related]
9. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes. Vidiri A; Gangemi E; Ruberto E; Pasqualoni R; Sciuto R; Sanguineti G; Farneti A; Benevolo M; Rollo F; Sperati F; Spasiano F; Pellini R; Marzi S PLoS One; 2020; 15(3):e0229611. PubMed ID: 32119697 [TBL] [Abstract][Full Text] [Related]
10. Comparison of F18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Dynamic Contrast-Enhanced Magnetic Resonance Imaging as Markers of Graft Viability in Anterior Cruciate Ligament Reconstruction. Garika SS; Sharma A; Razik A; Sharma A; Pandey RM; Gamanagatti S; Kumar R; Mittal R Am J Sports Med; 2019 Jan; 47(1):88-95. PubMed ID: 30481047 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography. Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080 [TBL] [Abstract][Full Text] [Related]
13. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and Tang L; Wang XJ; Baba H; Giganti F Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480 [TBL] [Abstract][Full Text] [Related]
14. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses. Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms. Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148 [TBL] [Abstract][Full Text] [Related]
16. Response assessment of stereotactic body radiation therapy using dynamic contrast-enhanced integrated MR-PET in non-small cell lung cancer patients. Huang YS; Chen JL; Hsu FM; Huang JY; Ko WC; Chen YC; Jaw FS; Yen RF; Chang YC J Magn Reson Imaging; 2018 Jan; 47(1):191-199. PubMed ID: 28480541 [TBL] [Abstract][Full Text] [Related]
17. Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience. Hectors SJ; Wagner M; Besa C; Huang W; Taouli B Contrast Media Mol Imaging; 2018; 2018():5638283. PubMed ID: 30402045 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. Magometschnigg HF; Baltzer PA; Fueger B; Helbich TH; Karanikas G; Dubsky P; Rudas M; Weber M; Pinker K Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1656-1665. PubMed ID: 26121928 [TBL] [Abstract][Full Text] [Related]